NATR stock forecast, quote, news & analysis

Key Takeaways

• NATR shares have traded roughly flat over the past 30 days, declining approximately 1.2% from $21.02 to $20.78, signaling a consolidation phase following a broader quarterly pullback of roughly 23%.
• Q1 2026 results exceeded analyst expectations, with EPS of $0.30 beating the $0.20 consensus and revenue reaching $122.89 million, driven by strong performance across all geographic segments.
• Digital transformation remains a core growth engine, with North American digital revenue surging 42% year-over-year in Q1 2026 alongside record new customer acquisition.
• China operations posted 40% constant-currency sales growth in Q1 2026, supported by rapid adoption of auto-ship subscription programs and double-digit consultant expansion.
• Analyst consensus stands at Strong Buy with an average 12-month price target of $35, implying approximately 69% upside from current levels.
• Q2 2026 earnings are scheduled for July 30, 2026, with analysts forecasting EPS of $0.27 on revenue of approximately $123.7 million.

Current Market Snapshot

Nature's Sunshine Products (NATR) has entered a period of relative price stability after experiencing a meaningful decline over the preceding quarter. The stock currently trades near $20.78, hovering just above a support zone in the $20.00–$20.50 range that has attracted buyers in recent weeks. Daily trading volumes have remained in line with the stock's average, suggesting neither panic selling nor aggressive accumulation. The broader consumer defensive and packaged-foods sector has shown mixed performance, but NATR's consolidation near its 50-day moving average of approximately $21 indicates that the market is in a wait-and-see posture ahead of the upcoming Q2 earnings report. Institutional ownership remains elevated at roughly 79%, with notable recent accumulation from firms including Hillsdale Investment Management, which boosted its position by over 44% in the first quarter.

Nature's Sunshine Products (NATR) Business Overview and Competitive Position

Nature's Sunshine Products, Inc. is a global natural health and wellness company headquartered in Lehi, Utah, with operations spanning more than 40 countries. Founded in 1972, the company manufactures and distributes over 600 nutritional supplements, herbal remedies, and personal care products under the Nature's Sunshine and Synergy Worldwide brands. Its product portfolio encompasses general health, immune support, cardiovascular care, digestive health, personal care, and weight management categories. The company operates through a hybrid distribution model combining a network of independent consultants with a rapidly expanding direct-to-consumer digital channel. Manufacturing is primarily conducted at its own facility in Utah, providing quality control and cost advantages. Asia represents the largest revenue segment, followed by North America, Europe, and Latin America. NATR maintains a debt-free balance sheet with approximately $87.6 million in cash, giving it significant financial flexibility to fund organic growth, pursue acquisitions, and execute share repurchases. The company's competitive moat rests on its vertically integrated manufacturing, clinical research capabilities through the Hughes Center, and strong brand heritage in the natural supplements space.

Recent Developments Driving NATR

The past 30 days have seen several notable developments for Nature's Sunshine Products. On July 6, DA Davidson upgraded NATR to a Strong-Buy rating, reinforcing positive analyst sentiment. This followed the company's Q1 2026 earnings report on May 7, which delivered an impressive beat: EPS of $0.30 versus $0.20 expected and revenue of $122.89 million, marking 9% year-over-year growth. All four geographic segments posted constant-currency increases, with North America leading at 9% growth. Management reaffirmed full-year 2026 guidance of $500 million to $515 million in revenue and adjusted EBITDA of $50 million to $54 million. The digital channel continues to show exceptional momentum, with North American digital sales climbing 42% year-over-year and subscription auto-ship now accounting for 48% of digital revenue. In China, sales surged 40% in constant currency, fueled by auto-ship adoption exceeding 25% of revenue and double-digit consultant growth. The company also appointed John Hnanicek as Chief Technology Officer to accelerate its technology infrastructure and digital capabilities. Additionally, NATR announced plans to enter Germany—the largest supplement market in Europe and its most significant new market entry since China in 2016. Partially offsetting the positive operational news, Weiss Ratings downgraded the stock to hold in early June, and insider selling activity by EVP Nathan Brower in May has drawn some investor attention. The company also continues to execute its $25 million share repurchase authorization, with approximately $16.9 million remaining.

Trending AI Robots

Investors seeking data-driven trading strategies may find valuable tools on Tickeron's Trending AI Robots page. Tickeron operates hundreds of AI-powered trading bots that monitor thousands of tickers across global markets, but only the highest-performing and most relevant bots are featured in this curated section. Each bot employs distinct strategies, timeframes, and performance metrics—ranging from short-term swing trading to longer-duration trend-following approaches—allowing users to identify models that align with their own investment style and risk tolerance. The platform continuously evaluates bot performance, ensuring that the showcased robots meet rigorous standards for consistency and profitability. Exploring this section can offer traders a transparent, data-backed complement to their own research process.

2026 Outlook and What Investors Should Watch

Looking ahead through the remainder of 2026, several catalysts and risk factors merit close attention. The immediate focus is the Q2 2026 earnings report scheduled for July 30, which will provide a critical update on whether the digital growth trajectory and China momentum have been sustained. Investors should monitor key metrics including digital customer acquisition rates, auto-ship adoption percentages, and constant-currency growth in Asia and Europe. The Germany market entry represents a significant long-term opportunity but will require upfront investment that may pressure near-term margins. Management's strategic investments in technology infrastructure, outlined during the Q1 earnings call, are expected to temporarily moderate EBITDA growth rates in Q2 and Q3 before yielding scale benefits in 2027. Macroeconomic risks include the Iran geopolitical situation, which management has flagged as a potential source of inflationary pressure on input costs and consumer spending patterns. On the regulatory front, Natur's Sunshine's network-marketing model remains subject to evolving compliance standards across multiple jurisdictions. The analyst community remains broadly bullish, with price targets ranging from $33 to $37, though sustained execution on the digital pivot and China integration will be essential to closing the gap between current trading levels and those targets. With a debt-free balance sheet and nearly $1 per share in annual earnings, NATR retains multiple levers to create shareholder value through organic growth, buybacks, and potential accretive M&A.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations